Blogs

Last Call! Register for the ACT Virtual 42nd Annual Meeting and Join Us November 10–19

By Timothy McGovern posted 11-02-2021 05:00 PM

  


Don't miss your chance to register for the virtual ACT 42nd Annual Meeting! Join us virtually November 10–19, 2021. Registering for the virtual meeting will allow you access to all the social events, including the Welcome Reception, and access to all the scientific content until February 15, 2022!

Features of the Virtual Meeting Will Include:

  • A Broad Range of Symposia and Workshops Crafted by ACT Members
  • The Popular Hot Topics Session
  • Two Plenary Lectures Discussing the Latest Research Developments in the Field
  • Poster Viewing Session Populated with Novel Research Methods and Findings
  • Awards Ceremony with a Distinguished Scientist Keynote Lecture
  • Talking Tox Webinars Showcasing Technologies and Services
  • A Variety of Professional Networking Opportunities
  • Customized Continuing Education Courses:
    The deadline to make changes to your CE course registration is November 3! If you would like to make any changes to your current course registration, email ACT Headquarters for assistance.
    • Wednesday, November 10: 12:00 Noon–4:00 PM Eastern Time
      CE 1: Microbiome and Drug Development
      CE 2: Designing Nonclinical Study Programs for Ocular Therapeutics and Drugs with Off-Target Ocular Effects
      CE 3: Practical Perspectives on Successful Regulatory Authoring: How to Avoid Common Mistakes and Minimize Pharmaceutical Development Delays
    • Friday, November 12: 12:00 Noon–4:00 PM Eastern Time
      CE 4: The Pre- and Postnatal Development Study (PPND) in the Rodent Post–ICH S5(R3) Guideline Revision
      CE 5: Conventional and Nonconventional Drug-Drug Interactions
      CE 6: Antibody Drug Conjugates (ADCs) as Cancer Therapies

Register Today!

Visit the ACT 42nd Annual Meeting website to find more details about the 2021 virtual event.

We look forward to "seeing" you soon!


#Annual
#meeting
#actox2021
#Virtual
0 comments
2 views

Permalink